Literature DB >> 28013514

Methods for Investigating Biofilm Inhibition and Degradation by Antimicrobial Peptides.

Li-Av Segev-Zarko1, Yechiel Shai2.   

Abstract

Multidrug-resistant bacteria are a growing problem worldwide. One extensively studied resistance mechanism is biofilm colonization-microbial colonies formed by many Gram-positive and Gram-negative bacteria species. Cationic antimicrobial peptides (AMPs) are innate immune system molecules serving as a first line of defense in fighting invading pathogens. The AMPs' underlying mechanism and biophysical properties required for anti-biofilm activity are not fully known. Here we present protocols for investigating AMPs' biological activity against major stages of biofilm life cycle, namely, planktonic stage (MIC assay), initial adhesion to surfaces (bacterial attachment assay), and formation or degradation of sessile microcolonies (biofilm formation and degradation assays). Furthermore, we demonstrate experiments that allow determination and comparison between peptide biophysical properties (secondary structure, hydrophobicity, and oligomerization) and how they affect their mechanism (peptide-binding assays) of anti-biofilm activity.

Entities:  

Keywords:  Anti-biofilm activity; Antimicrobial peptides; Biofilm; Biophysics

Mesh:

Substances:

Year:  2017        PMID: 28013514     DOI: 10.1007/978-1-4939-6737-7_22

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

1.  Antimicrobial Peptides against Multidrug-Resistant Pseudomonas aeruginosa Biofilm from Cystic Fibrosis Patients.

Authors:  Daniel Ben Hur; Gal Kapach; Naiem Ahmad Wani; Edo Kiper; Moshe Ashkenazi; Gill Smollan; Natan Keller; Ori Efrati; Yechiel Shai
Journal:  J Med Chem       Date:  2022-06-27       Impact factor: 8.039

2.  Noncytotoxic silver nanoparticles as a new antimicrobial strategy.

Authors:  Bartosz Skóra; Urszula Krajewska; Anna Nowak; Andrzej Dziedzic; Adriana Barylyak; Małgorzata Kus-Liśkiewicz
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.